George Sakoulas

Title(s)Adjunct Professor, Pediatrics
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Developmental and Translational Pharmacology of Pediatric Antimicrobial Therapy
    NIH U54HD071600Sep 26, 2011 - Jun 30, 2016
    Role: Co-Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Contemporary Management of Staphylococcus aureus Bacteremia: Some Additional Considerations for Clinicians. Clin Infect Dis. 2024 Mar 20. Sakoulas G, Tsou EE, Geriak M, Vasina L. PMID: 38507229.
      View in: PubMed   Mentions:    Fields:    
    2. Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study. Infect Dis Ther. 2024 Mar; 13(3):565-579. Rebold N, Alosaimy S, Pearson JC, Dionne B, Taqi A, Lagnf A, Lucas K, Biagi M, Lombardo N, Eudy J, Anderson DT, Mahoney MV, Kufel WD, D'Antonio JA, Jones BM, Frens JJ, Baumeister T, Geriak M, Sakoulas G, Farmakiotis D, Delaportas D, Larew J, Veve MP, Rybak MJ. PMID: 38427289; PMCID: PMC10965835.
      View in: PubMed   Mentions:
    3. Adjunctive Intravenous Immunoglobulin and Glucocorticoid Therapy in Severe Herpes Simplex Encephalitis with Excellent Outcome Begs for Larger Trials Evaluating Immunomodulatory Therapy. Am J Case Rep. 2024 Jan 14; 25:e941864. Sakoulas G, Roth J, Van der Kuy H. PMID: 38219011; PMCID: PMC10806373.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Measuring beta-lactam minimum inhibitory concentrations in Staphylococcus aureus in the clinical microbiology laboratory: pinning the tail on the donkey. J Clin Microbiol. 2024 01 17; 62(1):e0036623. Sakoulas G, Nizet V. PMID: 37966224; PMCID: PMC10793257.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    5. Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and β-lactam chemistry. Lancet Infect Dis. 2024 Mar; 24(3):e179-e188. Alosaimy S, Rybak MJ, Sakoulas G. PMID: 37883984.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Reply to Scheetz et al. Clin Infect Dis. 2023 04 17; 76(8):1522-1523. Alosaimy S, Rybak MJ, Sakoulas G. PMID: 36550065.
      View in: PubMed   Mentions:    Fields:    
    7. Unrecognized Potent Activities of Colistin Against Clinically Important mcr+ Enterobacteriaceae Revealed in Synergy with Host Immunity. bioRxiv. 2023 Mar 21. Kumaraswamy M, Riestra A, Flores A, Uchiyama S, Dahesh S, Bondsäter G, Nilsson V, Chang M, Seo H, Sakoulas G, Nizet V. PMID: 36993410; PMCID: PMC10055327.
      View in: PubMed   Mentions:
    8. Nafcillin Augmentation of Daptomycin and Cathelicidin LL-37 Killing of Methicillin-resistant Staphylococcus epidermidis: Foundations of Successful Therapy of Endocarditis. Int J Antimicrob Agents. 2023 Jun; 61(6):106758. Catteau L, Iglesias YD, Tsunemoto H, Pogliano J, Van Bambeke F, Nizet V, Sakoulas G. PMID: 36775256; PMCID: PMC10334303.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    9. Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-Tazobactam. Clin Infect Dis. 2023 02 08; 76(3):e1444-e1455. Alosaimy S, Lagnf AM, Hobbs ALV, Mubarez M, Kufel WD, Morrisette T, Polisetty RS, Li D, Veve MP, Simon SP, Truong J, Finch N, Venugopalan V, Rico M, Amaya L, Yost C, Cubillos A, Chandler E, Patch M, Smith IMK, Biagi M, Wrin J, Moore WJ, Molina KC, Rebold N, Holger D, Kunz Coyne AJ, Jorgensen SCJ, Witucki P, Tran NN, Davis SL, Sakoulas G, Rybak MJ. PMID: 35982631.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Omadacycline in treating community-based infections: a review and expert perspective. Expert Rev Anti Infect Ther. 2023 03; 21(3):255-265. Sakoulas G, Nowak M, Geriak M. PMID: 36718489.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    11. Abrogation of neutrophil inflammatory pathways and potential reduction of neutrophil-related factors in COVID-19 by intravenous immunoglobulin. Front Immunol. 2022; 13:993720. Masso-Silva JA, Sakoulas G, Olay J, Groysberg V, Geriak M, Nizet V, Crotty Alexander LE, Meier A. PMID: 36341409; PMCID: PMC9632428.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    12. Linezolid versus omadacycline in diabetic soft tissue infections: a signal of different adjunctive immunological properties? J Antimicrob Chemother. 2022 05 29; 77(6):1503-1505. Sakoulas G. PMID: 35141751.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Case Series of Successful Intravenous Immunoglobulin (IVIG) Treatment in 4 Pregnant Patients with Severe COVID-19-Induced Hypoxia. Am J Case Rep. 2022 May 14; 23:e936734. Geriak M, McGrosso D, Gonzalez DJ, Dehner M, Sakoulas G. PMID: 35567293; PMCID: PMC9115731.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    14. Azithromycin: An Underappreciated Quinolone-Sparing Oral Treatment for Pseudomonas aeruginosa Infections. Antibiotics (Basel). 2022 Apr 13; 11(4). Ulloa ER, Sakoulas G. PMID: 35453266; PMCID: PMC9024921.
      View in: PubMed   Mentions: 3  
    15. Impact of Clopidogrel on Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: a National Retrospective Cohort Study. Antimicrob Agents Chemother. 2022 06 21; 66(6):e0211721. Caffrey AR, Appaneal HJ, LaPlante KL, Lopes VV, Ulloa ER, Nizet V, Sakoulas G. PMID: 35416712; PMCID: PMC9211425.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    16. Approaching 65 Years: Is It Time to Consider Retirement of Vancomycin for Treating Methicillin-Resistant Staphylococcus aureus Endovascular Infections? Open Forum Infect Dis. 2022 May; 9(5):ofac137. Rose W, Volk C, Dilworth TJ, Sakoulas G. PMID: 35493116; PMCID: PMC9043000.
      View in: PubMed   Mentions: 3  
    17. Potent Activity of Ertapenem Plus Cefazolin Within Staphylococcal Biofilms: A Contributing Factor in the Treatment of Methicillin-Susceptible Staphylococcus aureus Endocarditis. Open Forum Infect Dis. 2022 May; 9(5):ofac159. Gilbertie J, Ulloa ER, Daiker JC, Nguyen K, Smelter D, Rose W, Geriak M, Schnabel LV, Nizet V, Sakoulas G. PMID: 35493130; PMCID: PMC9045957.
      View in: PubMed   Mentions:
    18. Is the Success of Cefazolin plus Ertapenem in Methicillin-Susceptible Staphylococcus aureus Bacteremia Based on Release of Interleukin-1 Beta? Antimicrob Agents Chemother. 2022 02 15; 66(2):e0216621. Smelter D, Hayney M, Sakoulas G, Rose W. PMID: 34978891; PMCID: PMC8846438.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    19. Expert Update on Acute Bacterial Skin and Skin Structure Infection Treatment Options in the Community Setting. J Fam Pract. 2022 01; 71(Suppl 1 Bacterial):S2-S8. Sakoulas G. PMID: 35413233.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Current Paradigms of Combination Therapy in Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia: Does it Work, Which Combination, and For Which Patients? Clin Infect Dis. 2021 12 16; 73(12):2353-2360. Rose W, Fantl M, Geriak M, Nizet V, Sakoulas G. PMID: 33993226; PMCID: PMC8826002.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    21. Ticagrelor Increases Platelet-Mediated Staphylococcus aureus Killing, Resulting in Clearance of Bacteremia. J Infect Dis. 2021 11 16; 224(9):1566-1569. Ulloa ER, Uchiyama S, Gillespie R, Nizet V, Sakoulas G. PMID: 33966075; PMCID: PMC8599881.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    22. Acute Psychosis Due to Anti-N-Methyl D-Aspartate Receptor Encephalitis Following COVID-19 Vaccination: A Case Report. Front Neurol. 2021; 12:764197. Flannery P, Yang I, Keyvani M, Sakoulas G. PMID: 34803896; PMCID: PMC8599934.
      View in: PubMed   Mentions: 16  
    23. Bacterial Membrane-Derived Vesicles Attenuate Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus. Microorganisms. 2021 Sep 29; 9(10). Kumaraswamy M, Wiull K, Joshi B, Sakoulas G, Kousha A, Vaaje-Kolstad G, Johannessen M, Hegstad K, Nizet V, Askarian F. PMID: 34683376; PMCID: PMC8539228.
      View in: PubMed   Mentions: 3  
    24. Vancomycin or Daptomycin for Outpatient Parenteral Antibiotic Therapy: Does It Make a Difference in Patient Satisfaction? Open Forum Infect Dis. 2021 Aug; 8(8):ofab418. Wu KH, Sakoulas G, Geriak M. PMID: 34476284; PMCID: PMC8404740.
      View in: PubMed   Mentions: 3  
    25. Environmental conditions dictate differential evolution of vancomycin resistance in Staphylococcus aureus. Commun Biol. 2021 06 25; 4(1):793. Machado H, Seif Y, Sakoulas G, Olson CA, Hefner Y, Anand A, Jones YZ, Szubin R, Palsson BO, Nizet V, Feist AM. PMID: 34172889; PMCID: PMC8233327.
      View in: PubMed   Mentions: 9  Translation:HumansCells
    26. Clinical Efficacy of Patients With Secondary Bacteremia Treated With Omadacycline: Results From Phase 3 Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia Studies. Open Forum Infect Dis. 2021 Jun; 8(6):ofab136. Sakoulas G, Eckburg PB, Amodio-Groton M, Manley A, Tzanis E, Das AF, Noble R, McGovern PC. PMID: 34160473; PMCID: PMC8212941.
      View in: PubMed   Mentions: 2  
    27. Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia. Infect Dis Ther. 2021 Sep; 10(3):1323-1330. Geriak M, Haddad F, Kullar R, Greenwood KL, Habib M, Habib C, Willms D, Sakoulas G. PMID: 33977506; PMCID: PMC8112834.
      View in: PubMed   Mentions: 16  
    28. Repurposed drugs block toxin-driven platelet clearance by the hepatic Ashwell-Morell receptor to clear Staphylococcus aureus bacteremia. Sci Transl Med. 2021 03 24; 13(586). Sun J, Uchiyama S, Olson J, Morodomi Y, Cornax I, Ando N, Kohno Y, Kyaw MMT, Aguilar B, Haste NM, Kanaji S, Kanaji T, Rose WE, Sakoulas G, Marth JD, Nizet V. PMID: 33762439; PMCID: PMC9121309.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    29. Case Commentary: Imipenem/Cilastatin and Fosfomycin for Refractory Methicillin-Resistant Staphylococcus aureus Infection: a Novel Combination Therapy. Antimicrob Agents Chemother. 2020 12 16; 65(1). Sakoulas G. PMID: 33020155; PMCID: PMC7927839.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    30. Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series. Respiration. 2020; 99(12):1145-1153. Herth FJF, Sakoulas G, Haddad F. PMID: 33316806; PMCID: PMC7801971.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    31. Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019. Crit Care Explor. 2020 Nov; 2(11):e0280. Sakoulas G, Geriak M, Kullar R, Greenwood KL, Habib M, Vyas A, Ghafourian M, Dintyala VNK, Haddad F. PMID: 33225306; PMCID: PMC7671875.
      View in: PubMed   Mentions: 34  
    32. Synergistic Effects of Pulsed Lavage and Antimicrobial Therapy Against Staphylococcus aureus Biofilms in an in-vitro Model. Front Med (Lausanne). 2020; 7:527. Poilvache H, Ruiz-Sorribas A, Sakoulas G, Rodriguez-Villalobos H, Cornu O, Van Bambeke F. PMID: 33043028; PMCID: PMC7527469.
      View in: PubMed   Mentions: 6  
    33. Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia. Clin Infect Dis. 2020 09 12; 71(6):1413-1418. Ulloa ER, Singh KV, Geriak M, Haddad F, Murray BE, Nizet V, Sakoulas G. PMID: 31773134; PMCID: PMC7486850.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    34. Mortality Risk Profiling of Staphylococcus aureus Bacteremia by Multi-omic Serum Analysis Reveals Early Predictive and Pathogenic Signatures. Cell. 2020 09 03; 182(5):1311-1327.e14. Wozniak JM, Mills RH, Olson J, Caldera JR, Sepich-Poore GD, Carrillo-Terrazas M, Tsai CM, Vargas F, Knight R, Dorrestein PC, Liu GY, Nizet V, Sakoulas G, Rose W, Gonzalez DJ. PMID: 32888495; PMCID: PMC7494005.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    35. Antibiotics and Innate Immunity: A Cooperative Effort Toward the Successful Treatment of Infections. Open Forum Infect Dis. 2020 Aug; 7(8):ofaa302. Berti A, Rose W, Nizet V, Sakoulas G. PMID: 32818143; PMCID: PMC7423293.
      View in: PubMed   Mentions: 12  
    36. Interleukin (IL)-1β and IL-10 Host Responses in Patients With Staphylococcus aureus Bacteremia Determined by Antimicrobial Therapy. Clin Infect Dis. 2020 06 10; 70(12):2634-2640. Volk CF, Burgdorf S, Edwardson G, Nizet V, Sakoulas G, Rose WE. PMID: 31365924; PMCID: PMC7286365.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    37. Genome Sequence Comparison of Staphylococcus aureus TX0117 and a Beta-Lactamase-Cured Derivative Shows Increased Cationic Peptide Resistance Accompanying Mutations in relA and mnaA. Microbiol Resour Announc. 2020 Apr 30; 9(18). Sales MJ, Sakoulas G, Szubin R, Palsson B, Arias C, Singh KV, Murray BE, Monk JM. PMID: 32354985; PMCID: PMC7193940.
      View in: PubMed   Mentions: 2  
    38. Genetic Determinants Enabling Medium-Dependent Adaptation to Nafcillin in Methicillin-Resistant Staphylococcus aureus. mSystems. 2020 Mar 31; 5(2). Salazar MJ, Machado H, Dillon NA, Tsunemoto H, Szubin R, Dahesh S, Pogliano J, Sakoulas G, Palsson BO, Nizet V, Feist AM. PMID: 32234776; PMCID: PMC7112963.
      View in: PubMed   Mentions: 4     Fields:    
    39. Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus with Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis. Antimicrob Agents Chemother. 2020 02 21; 64(3). Miller CR, Dey S, Smolenski PD, Kulkarni PS, Monk JM, Szubin R, Sakoulas G, Berti AD. PMID: 31932377; PMCID: PMC7038235.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    40. Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments. Open Forum Infect Dis. 2020 Jan; 7(1):ofz538. McCreary EK, Kullar R, Geriak M, Zasowski EJ, Rizvi K, Schulz LT, Ouellette K, Vasina L, Haddad F, Rybak MJ, Zervos MJ, Sakoulas G, Rose WE. PMID: 31938716; PMCID: PMC6951465.
      View in: PubMed   Mentions: 33  
    41. Reduced Production of Bacterial Membrane Vesicles Predicts Mortality in ST45/USA600 Methicillin-Resistant Staphylococcus aureus Bacteremia. Antibiotics (Basel). 2019 Dec 18; 9(1). Dey S, Gudipati S, Giuliano C, Zervos MJ, Monk JM, Szubin R, Jorgensen SCJ, Sakoulas G, Berti AD. PMID: 31861446; PMCID: PMC7168145.
      View in: PubMed   Mentions: 5  
    42. Azithromycin Exerts Bactericidal Activity and Enhances Innate Immune Mediated Killing of MDR Achromobacter xylosoxidans. Infect Microbes Dis. 2020 Mar; 2(1):10-17. Ulloa ER, Kousha A, Tsunemoto H, Pogliano J, Licitra C, LiPuma JJ, Sakoulas G, Nizet V, Kumaraswamy M. PMID: 38500653; PMCID: PMC10947418.
      View in: PubMed   Mentions: 2  
    43. Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?" Antimicrob Agents Chemother. 2019 11; 63(11). Sakoulas G, Geriak M, Haddad F, Rose W, LaPlante K, Zervos M, Kullar R, Nizet V. PMID: 31640978; PMCID: PMC6811430.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    44. Omadacycline for Acute Bacterial Skin and Skin Structure Infections. Clin Infect Dis. 2019 08 01; 69(Suppl 1):S23-S32. Abrahamian FM, Sakoulas G, Tzanis E, Manley A, Steenbergen J, Das AF, Eckburg PB, McGovern PC. PMID: 31367742; PMCID: PMC6669297.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCellsCTClinical Trials
    45. Surprising synergy of dual translation inhibition vs. Acinetobacter baumannii and other multidrug-resistant bacterial pathogens. EBioMedicine. 2019 Aug; 46:193-201. Dillon N, Holland M, Tsunemoto H, Hancock B, Cornax I, Pogliano J, Sakoulas G, Nizet V. PMID: 31353294; PMCID: PMC6711115.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    46. Avibactam Sensitizes Carbapenem-Resistant NDM-1-Producing Klebsiella pneumoniae to Innate Immune Clearance. J Infect Dis. 2019 07 02; 220(3):484-493. Ulloa ER, Dillon N, Tsunemoto H, Pogliano J, Sakoulas G, Nizet V. PMID: 30923801; PMCID: PMC6603980.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    47. Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin. Antimicrob Agents Chemother. 2019 07; 63(7). Dahesh S, Wong B, Nizet V, Sakoulas G, Tran TT, Aitken SL. PMID: 31235559; PMCID: PMC6591586.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    48. Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2019 05; 63(5). Geriak M, Haddad F, Rizvi K, Rose W, Kullar R, LaPlante K, Yu M, Vasina L, Ouellette K, Zervos M, Nizet V, Sakoulas G. PMID: 30858203; PMCID: PMC6496065.
      View in: PubMed   Mentions: 69     Fields:    Translation:HumansCells
    49. Proton-pump inhibitors do not influence clinical outcomes in patients with Staphylococcus aureus bacteremia. Therap Adv Gastroenterol. 2019; 12:1756284819834273. Caffrey AR, Timbrook TT, Ali SR, Nizet V, Sakoulas G. PMID: 30923573; PMCID: PMC6431768.
      View in: PubMed   Mentions: 1  
    50. Is a Reported Penicillin Allergy Sufficient Grounds to Forgo the Multidimensional Antimicrobial Benefits of β-Lactam Antibiotics? Clin Infect Dis. 2019 01 01; 68(1):157-164. Sakoulas G, Geriak M, Nizet V. PMID: 29986019; PMCID: PMC6293005.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    51. Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus. PLoS One. 2018; 13(6):e0198366. Ma Z, Lasek-Nesselquist E, Lu J, Schneider R, Shah R, Oliva G, Pata J, McDonough K, Pai MP, Rose WE, Sakoulas G, Malik M. PMID: 29879195; PMCID: PMC5991675.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    52. The Staphylococcus aureus Two-Component System AgrAC Displays Four Distinct Genomic Arrangements That Delineate Genomic Virulence Factor Signatures. Front Microbiol. 2018; 9:1082. Choudhary KS, Mih N, Monk J, Kavvas E, Yurkovich JT, Sakoulas G, Palsson BO. PMID: 29887846; PMCID: PMC5981134.
      View in: PubMed   Mentions: 12  
    53. Prevention of High-Level Daptomycin-Resistance Emergence In Vitro in Streptococcus mitis-oralis by Using Combination Antimicrobial Strategies. Curr Microbiol. 2018 Aug; 75(8):1062-1067. Zapata B, Alvarez DN, Farah S, Garcia-de-la-Maria C, Miro JM, Sakoulas G, Bayer AS, Mishra NN. PMID: 29651552.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    54. Impact of cefazolin co-administration with vancomycin to reduce development of vancomycin-intermediate Staphylococcus aureus. Diagn Microbiol Infect Dis. 2018 Aug; 91(4):363-370. Singh NB, Yim J, Jahanbakhsh S, Sakoulas G, Rybak MJ. PMID: 29807674.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    55. Humanized Exposures of a β-Lactam-β-Lactamase Inhibitor, Tazobactam, versus Non-β-Lactam-β-Lactamase Inhibitor, Avibactam, with or without Colistin, against Acinetobacter baumannii in Murine Thigh and Lung Infection Models. Pharmacology. 2018; 101(5-6):255-261. Monogue ML, Sakoulas G, Nizet V, Nicolau DP. PMID: 29533955.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    56. Telavancin for refractory MRSA bacteraemia in intermittent haemodialysis recipients. J Antimicrob Chemother. 2018 03 01; 73(3):764-767. Britt NS, Tirmizi S, Ritchie DJ, Topal JE, McManus D, Nizet V, Casabar E, Sakoulas G. PMID: 29244141; PMCID: PMC5890690.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    57. Listeria monocytogenes endocarditis: case report, review of the literature, and laboratory evaluation of potential novel antibiotic synergies. Int J Antimicrob Agents. 2018 Mar; 51(3):468-478. Kumaraswamy M, Do C, Sakoulas G, Nonejuie P, Tseng GW, King H, Fierer J, Pogliano J, Nizet V. PMID: 29337066; PMCID: PMC5860678.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    58. Interaction of Antibiotics with Innate Host Defense Factors against Salmonella enterica Serotype Newport. mSphere. 2017 Nov-Dec; 2(6). Sakoulas G, Kumaraswamy M, Kousha A, Nizet V. PMID: 29242830; PMCID: PMC5717323.
      View in: PubMed   Mentions: 22     Fields:    
    59. Dissecting Out the Direct Impacts of Large-Scale Antimicrobial Stewardship Interventions on Clinical Outcomes: Can Confounding Be Overcome? Clin Infect Dis. 2017 11 13; 65(11):1956-1957. Dilworth TJ, Rose WE, Sakoulas G, Bayer AS. PMID: 29020207.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    60. Increased Endovascular Staphylococcus aureus Inoculum Is the Link Between Elevated Serum Interleukin 10 Concentrations and Mortality in Patients With Bacteremia. Clin Infect Dis. 2017 May 15; 64(10):1406-1412. Rose WE, Shukla SK, Berti AD, Hayney MS, Henriquez KM, Ranzoni A, Cooper MA, Proctor RA, Nizet V, Sakoulas G. PMID: 28205673; PMCID: PMC5411397.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    61. Evidence To Support Continuation of Statin Therapy in Patients with Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2017 03; 61(3). Caffrey AR, Timbrook TT, Noh E, Sakoulas G, Opal SM, Nizet V, LaPlante KL. PMID: 28069650; PMCID: PMC5328562.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    62. Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumannii. Antimicrob Agents Chemother. 2017 02; 61(2). Sakoulas G, Rose W, Berti A, Olson J, Munguia J, Nonejuie P, Sakoulas E, Rybak MJ, Pogliano J, Nizet V. PMID: 27872080; PMCID: PMC5278754.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    63. β-Lactamase Inhibitors Enhance the Synergy between β-Lactam Antibiotics and Daptomycin against Methicillin-Resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2017 01; 61(1). Henson KE, Yim J, Smith JR, Sakoulas G, Rybak MJ. PMID: 27821441; PMCID: PMC5192128.
      View in: PubMed   Mentions: 5     Fields:    Translation:Cells
    64. Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2016 11; 60(11):6609-6618. Sakoulas G, Olson J, Yim J, Singh NB, Kumaraswamy M, Quach DT, Rybak MJ, Pogliano J, Nizet V. PMID: 27572414; PMCID: PMC5075066.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansAnimalsCells
    65. Fosfomycin Enhances the Activity of Daptomycin against Vancomycin-Resistant Enterococci in an In Vitro Pharmacokinetic-Pharmacodynamic Model. Antimicrob Agents Chemother. 2016 10; 60(10):5716-23. Hall Snyder AD, Werth BJ, Nonejuie P, McRoberts JP, Pogliano J, Sakoulas G, Yim J, Singh N, Rybak MJ. PMID: 27431211; PMCID: PMC5038233.
      View in: PubMed   Mentions: 18     Fields:    Translation:Cells
    66. Effects of vancomycin versus nafcillin in enhancing killing of methicillin-susceptible Staphylococcus aureus causing bacteremia by human cathelicidin LL-37. Eur J Clin Microbiol Infect Dis. 2016 Sep; 35(9):1441-7. Le J, Dam Q, Schweizer M, Thienphrapa W, Nizet V, Sakoulas G. PMID: 27234592; PMCID: PMC4983239.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    67. New Guidelines Endorse Old Recommendations for Invasive Enterococcal Infections. Clin Infect Dis. 2016 07 15; 63(2):281-2. Werth BJ, Smith JR, Sakoulas G. PMID: 27161781.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    68. Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial. J Antimicrob Chemother. 2016 07; 71(7):2014-21. Huntington JA, Sakoulas G, Umeh O, Cloutier DJ, Steenbergen JN, Bliss C, Goldstein EJ. PMID: 26994090.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    69. Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophilia. J Antimicrob Chemother. 2016 May; 71(5):1264-9. Kumaraswamy M, Lin L, Olson J, Sun CF, Nonejuie P, Corriden R, Döhrmann S, Ali SR, Amaro D, Rohde M, Pogliano J, Sakoulas G, Nizet V. PMID: 26832758; PMCID: PMC4830416.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansAnimalsCells
    70. Bacterial Cytological Profiling (BCP) as a Rapid and Accurate Antimicrobial Susceptibility Testing Method for Staphylococcus aureus. EBioMedicine. 2016 Feb; 4:95-103. Quach DT, Sakoulas G, Nizet V, Pogliano J, Pogliano K. PMID: 26981574; PMCID: PMC4776060.
      View in: PubMed   Mentions: 32     Fields:    Translation:Cells
    71. When sepsis persists: a review of MRSA bacteraemia salvage therapy. J Antimicrob Chemother. 2016 Mar; 71(3):576-86. Kullar R, Sakoulas G, Deresinski S, van Hal SJ. PMID: 26565015.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    72. Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam-Daptomycin Synergy. Antimicrob Agents Chemother. 2016 01; 60(1):451-8. Berti AD, Theisen E, Sauer JD, Nonejuie P, Olson J, Pogliano J, Sakoulas G, Nizet V, Proctor RA, Rose WE. PMID: 26525797; PMCID: PMC4704217.
      View in: PubMed   Mentions: 27     Fields:    Translation:Cells
    73. Differential Effects of Penicillin Binding Protein Deletion on the Susceptibility of Enterococcus faecium to Cationic Peptide Antibiotics. Antimicrob Agents Chemother. 2015 Oct; 59(10):6132-9. Sakoulas G, Kumaraswamy M, Nonejuie P, Werth BJ, Rybak MJ, Pogliano J, Rice LB, Nizet V. PMID: 26195528; PMCID: PMC4576044.
      View in: PubMed   Mentions: 3     Fields:    Translation:Cells
    74. Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens. EBioMedicine. 2015 Jul; 2(7):690-8. Lin L, Nonejuie P, Munguia J, Hollands A, Olson J, Dam Q, Kumaraswamy M, Rivera H, Corriden R, Rohde M, Hensler ME, Burkart MD, Pogliano J, Sakoulas G, Nizet V. PMID: 26288841; PMCID: PMC4534682.
      View in: PubMed   Mentions: 131     Fields:    Translation:HumansAnimalsCells
    75. Agranulocytosis with ceftaroline high-dose monotherapy or combination therapy with clindamycin. Pharmacotherapy. 2015 Jun; 35(6):608-12. Varada NL, Sakoulas G, Lei LR, Chua J. PMID: 26037689.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    76. Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia. Clin Ther. 2015 Jul 01; 37(7):1443-1453.e2. Moise PA, Sakoulas G, McKinnell JA, Lamp KC, DePestel DD, Yoon MJ, Reyes K, Zervos MJ. PMID: 25982687.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    77. In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci. Antimicrob Agents Chemother. 2015 Jul; 59(7):4279-88. Hindler JA, Wong-Beringer A, Charlton CL, Miller SA, Kelesidis T, Carvalho M, Sakoulas G, Nonejuie P, Pogliano J, Nizet V, Humphries R. PMID: 25963982; PMCID: PMC4468720.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    78. Staphylococcus aureus bacteraemia management: where do we stand and where are we going? Evid Based Med. 2015 Aug; 20(4):126. Moise PA, Sakoulas G. PMID: 25895528.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    79. Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics. Antimicrob Agents Chemother. 2015 May; 59(5):2799-806. Berti AD, Baines SL, Howden BP, Sakoulas G, Nizet V, Proctor RA, Rose WE. PMID: 25733508; PMCID: PMC4394801.
      View in: PubMed   Mentions: 23     Fields:    Translation:Cells
    80. β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium. J Antimicrob Chemother. 2015; 70(6):1738-43. Smith JR, Barber KE, Raut A, Aboutaleb M, Sakoulas G, Rybak MJ. PMID: 25645208; PMCID: PMC4542582.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    81. Examining the use of ceftaroline in the treatment of Streptococcus pneumoniae meningitis with reference to human cathelicidin LL-37. Antimicrob Agents Chemother. 2015 Apr; 59(4):2428-31. Sakoulas G, Nonejuie P, Kullar R, Pogliano J, Rybak MJ, Nizet V. PMID: 25605351; PMCID: PMC4356754.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    82. Comment on: Failure of combination therapy with daptomycin and synergistic ceftriaxone for enterococcal endocarditis. J Antimicrob Chemother. 2015 Apr; 70(4):1272-3. Hall Snyder A, Werth BJ, Barber KE, Sakoulas G, Rybak MJ. PMID: 25433012.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    83. Reply to Eschenauer et al. Clin Infect Dis. 2015 Feb 15; 60(4):671-2. Kullar R, McKinnell JA, Sakoulas G. PMID: 25371486; PMCID: PMC4809982.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    84. Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and -resistant VRE. J Antimicrob Chemother. 2015 Feb; 70(2):489-93. Werth BJ, Barber KE, Tran KN, Nonejuie P, Sakoulas G, Pogliano J, Rybak MJ. PMID: 25304643.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    85. Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides. Antimicrob Agents Chemother. 2014 Dec; 58(12):7462-7. Bayer AS, Mishra NN, Sakoulas G, Nonejuie P, Nast CC, Pogliano J, Chen KT, Ellison SN, Yeaman MR, Yang SJ. PMID: 25288091; PMCID: PMC4249560.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    86. Daptomycin in combination with other antibiotics for the treatment of complicated methicillin-resistant Staphylococcus aureus bacteremia. Clin Ther. 2014 Oct 01; 36(10):1303-16. Dhand A, Sakoulas G. PMID: 25444563.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    87. Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia. J Antimicrob Chemother. 2015 Jan; 70(1):311-3. Barber KE, Rybak MJ, Sakoulas G. PMID: 25125677.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    88. Avoiding the perfect storm: the biologic and clinical case for reevaluating the 7-day expectation for methicillin-resistant Staphylococcus aureus bacteremia before switching therapy. Clin Infect Dis. 2014 Nov 15; 59(10):1455-61. Kullar R, McKinnell JA, Sakoulas G. PMID: 25048852; PMCID: PMC4215066.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    89. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline. Clin Ther. 2014 Oct 01; 36(10):1317-33. Sakoulas G, Moise PA, Casapao AM, Nonejuie P, Olson J, Okumura CY, Rybak MJ, Kullar R, Dhand A, Rose WE, Goff DA, Bressler AM, Lee Y, Pogliano J, Johns S, Kaatz GW, Ebright JR, Nizet V. PMID: 25017183.
      View in: PubMed   Mentions: 76     Fields:    Translation:HumansAnimalsCells
    90. Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes. J Antimicrob Chemother. 2014 Nov; 69(11):3006-10. Barber KE, Werth BJ, Ireland CE, Stone NE, Nonejuie P, Sakoulas G, Pogliano J, Rybak MJ. PMID: 24990867.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    91. Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis. Antimicrob Agents Chemother. 2014 Sep; 58(9):5253-61. Werth BJ, Steed ME, Ireland CE, Tran TT, Nonejuie P, Murray BE, Rose WE, Sakoulas G, Pogliano J, Arias CA, Rybak MJ. PMID: 24957825; PMCID: PMC4135850.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    92. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model. J Antimicrob Chemother. 2014 Aug; 69(8):2148-54. Hall Snyder A, Werth BJ, Barber KE, Sakoulas G, Rybak MJ. PMID: 24777900.
      View in: PubMed   Mentions: 27     Fields:    Translation:Cells
    93. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis. Pharmacotherapy. 2014 Jun; 34(6):582-9. Kullar R, McClellan I, Geriak M, Sakoulas G. PMID: 24658897.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    94. Human cathelicidin LL-37 resistance and increased daptomycin MIC in methicillin-resistant Staphylococcus aureus strain USA600 (ST45) are associated with increased mortality in a hospital setting. J Clin Microbiol. 2014 Jun; 52(6):2172-4. Sakoulas G, Guram K, Reyes K, Nizet V, Zervos M. PMID: 24648548; PMCID: PMC4042812.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    95. Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 2014; 58(3):1494-500. Sakoulas G, Rose W, Nonejuie P, Olson J, Pogliano J, Humphries R, Nizet V. PMID: 24366742; PMCID: PMC3957885.
      View in: PubMed   Mentions: 43     Fields:    Translation:Cells
    96. Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus. J Mol Med (Berl). 2014 Feb; 92(2):139-49. Sakoulas G, Okumura CY, Thienphrapa W, Olson J, Nonejuie P, Dam Q, Dhand A, Pogliano J, Yeaman MR, Hensler ME, Bayer AS, Nizet V. PMID: 24297496; PMCID: PMC3926703.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansAnimalsCells
    97. Reduced glycopeptide and lipopeptide susceptibility in Staphylococcus aureus and the "seesaw effect": Taking advantage of the back door left open? Drug Resist Updat. 2013 Jul-Nov; 16(3-5):73-9. Ortwine JK, Werth BJ, Sakoulas G, Rybak MJ. PMID: 24268586.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    98. A current perspective on daptomycin for the clinical microbiologist. Clin Microbiol Rev. 2013 Oct; 26(4):759-80. Humphries RM, Pollett S, Sakoulas G. PMID: 24092854; PMCID: PMC3811228.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCells
    99. Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus. J Infect Dis. 2014 Feb 15; 209(4):571-7. Calderwood MS, Desjardins CA, Sakoulas G, Nicol R, Dubois A, Delaney ML, Kleinman K, Cosimi LA, Feldgarden M, Onderdonk AB, Birren BW, Platt R, Huang SS, CDC Prevention Epicenters Program. PMID: 24041793; PMCID: PMC3903375.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    100. A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis. J Antimicrob Chemother. 2013 Dec; 68(12):2921-6. Kullar R, Casapao AM, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ. PMID: 23928022; PMCID: PMC3820108.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    101. β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2013 Oct; 57(10):5005-12. Berti AD, Sakoulas G, Nizet V, Tewhey R, Rose WE. PMID: 23896478; PMCID: PMC3811465.
      View in: PubMed   Mentions: 45     Fields:    Translation:Cells
    102. Multicenter study of high-dose daptomycin for treatment of enterococcal infections. Antimicrob Agents Chemother. 2013 Sep; 57(9):4190-6. Casapao AM, Kullar R, Davis SL, Levine DP, Zhao JJ, Potoski BA, Goff DA, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ. PMID: 23774437; PMCID: PMC3754344.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    103. Treatment of high-level gentamicin-resistant Enterococcus faecalis endocarditis with daptomycin plus ceftaroline. Antimicrob Agents Chemother. 2013 Aug; 57(8):4042-5. Sakoulas G, Nonejuie P, Nizet V, Pogliano J, Crum-Cianflone N, Haddad F. PMID: 23689728; PMCID: PMC3719745.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCells
    104. Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus. J Infect Dis. 2013 Jul; 208(1):67-74. Vidaillac C, Gardete S, Tewhey R, Sakoulas G, Kaatz GW, Rose WE, Tomasz A, Rybak MJ. PMID: 23539745; PMCID: PMC3666135.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    105. Novel combinations of vancomycin plus ceftaroline or oxacillin against methicillin-resistant vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA. Antimicrob Agents Chemother. 2013 May; 57(5):2376-9. Werth BJ, Vidaillac C, Murray KP, Newton KL, Sakoulas G, Nonejuie P, Pogliano J, Rybak MJ. PMID: 23422917; PMCID: PMC3632910.
      View in: PubMed   Mentions: 25     Fields:    Translation:Cells
    106. Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant β-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment. Antimicrob Agents Chemother. 2013 Mar; 57(3):1192-200. Moise PA, Amodio-Groton M, Rashid M, Lamp KC, Hoffman-Roberts HL, Sakoulas G, Yoon MJ, Schweitzer S, Rastogi A. PMID: 23254428; PMCID: PMC3591880.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    107. Microbiological profile of organisms causing bloodstream infection in critically ill patients. J Clin Med Res. 2012 Dec; 4(6):371-7. Orsini J, Mainardi C, Muzylo E, Karki N, Cohen N, Sakoulas G. PMID: 23226169; PMCID: PMC3513418.
      View in: PubMed   Mentions: 17  
    108. Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother. 2013 Jan; 57(1):66-73. Werth BJ, Sakoulas G, Rose WE, Pogliano J, Tewhey R, Rybak MJ. PMID: 23070161; PMCID: PMC3535972.
      View in: PubMed   Mentions: 62     Fields:    Translation:Cells
    109. Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus. J Antibiot (Tokyo). 2012 Dec; 65(12):593-8. Haste NM, Thienphrapa W, Tran DN, Loesgen S, Sun P, Nam SJ, Jensen PR, Fenical W, Sakoulas G, Nizet V, Hensler ME. PMID: 23047246; PMCID: PMC3528839.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    110. Elevated serum interleukin-10 at time of hospital admission is predictive of mortality in patients with Staphylococcus aureus bacteremia. J Infect Dis. 2012 Nov 15; 206(10):1604-11. Rose WE, Eickhoff JC, Shukla SK, Pantrangi M, Rooijakkers S, Cosgrove SE, Nizet V, Sakoulas G. PMID: 22966128; PMCID: PMC6281403.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCells
    111. Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 2012 Nov; 56(11):6051-3. Humphries RM, Kelesidis T, Tewhey R, Rose WE, Schork N, Nizet V, Sakoulas G. PMID: 22948885; PMCID: PMC3486580.
      View in: PubMed   Mentions: 39     Fields:    Translation:Cells
    112. Reduced susceptibility to host-defense cationic peptides and daptomycin coemerge in methicillin-resistant Staphylococcus aureus from daptomycin-naive bacteremic patients. J Infect Dis. 2012 Oct; 206(8):1160-7. Mishra NN, Bayer AS, Moise PA, Yeaman MR, Sakoulas G. PMID: 22904338; PMCID: PMC3448966.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    113. Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics. Antimicrob Agents Chemother. 2012 Oct; 56(10):5046-53. Berti AD, Wergin JE, Girdaukas GG, Hetzel SJ, Sakoulas G, Rose WE. PMID: 22802248; PMCID: PMC3457407.
      View in: PubMed   Mentions: 25     Fields:    Translation:Cells
    114. Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy. F1000 Med Rep. 2012; 4:4. Dhand A, Sakoulas G. PMID: 22312414; PMCID: PMC3270590.
      View in: PubMed   Mentions: 32  
    115. Novel bacterial metabolite merochlorin A demonstrates in vitro activity against multi-drug resistant methicillin-resistant Staphylococcus aureus. PLoS One. 2012; 7(1):e29439. Sakoulas G, Nam SJ, Loesgen S, Fenical W, Jensen PR, Nizet V, Hensler M. PMID: 22279537; PMCID: PMC3261149.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansAnimalsCells
    116. Pharmacological inhibition of the ClpXP protease increases bacterial susceptibility to host cathelicidin antimicrobial peptides and cell envelope-active antibiotics. Antimicrob Agents Chemother. 2012 Apr; 56(4):1854-61. McGillivray SM, Tran DN, Ramadoss NS, Alumasa JN, Okumura CY, Sakoulas G, Vaughn MM, Zhang DX, Keiler KC, Nizet V. PMID: 22252821; PMCID: PMC3318395.
      View in: PubMed   Mentions: 27     Fields:    Translation:Cells
    117. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother. 2012 Feb; 56(2):838-44. Sakoulas G, Bayer AS, Pogliano J, Tsuji BT, Yang SJ, Mishra NN, Nizet V, Yeaman MR, Moise PA. PMID: 22123698; PMCID: PMC3264218.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansCells
    118. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis. 2011 Oct 19; 11:279. Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, Perencevich EN. PMID: 22011388; PMCID: PMC3206863.
      View in: PubMed   Mentions: 95     Fields:    Translation:HumansCells
    119. Concentration-dependent effects of antimicrobials on Staphylococcus aureus toxin-mediated cytokine production from peripheral blood mononuclear cells. J Antimicrob Chemother. 2012 Jan; 67(1):123-9. Pichereau S, Moran JJ, Hayney MS, Shukla SK, Sakoulas G, Rose WE. PMID: 21980070.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    120. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2011 Oct; 66(10):2386-92. Walraven CJ, North MS, Marr-Lyon L, Deming P, Sakoulas G, Mercier RC. PMID: 21775337.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    121. Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding. Clin Infect Dis. 2011 Jul 15; 53(2):158-63. Dhand A, Bayer AS, Pogliano J, Yang SJ, Bolaris M, Nizet V, Wang G, Sakoulas G. PMID: 21690622; PMCID: PMC3697476.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCells
    122. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study. Pharmacotherapy. 2011 Jun; 31(6):527-36. Kullar R, Davis SL, Levine DP, Zhao JJ, Crank CW, Segreti J, Sakoulas G, Cosgrove SE, Rybak MJ. PMID: 21923436.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    123. Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach. J Antimicrob Chemother. 2011 Aug; 66(8):1696-711. Fischer A, Yang SJ, Bayer AS, Vaezzadeh AR, Herzig S, Stenz L, Girard M, Sakoulas G, Scherl A, Yeaman MR, Proctor RA, Schrenzel J, François P. PMID: 21622973; PMCID: PMC3133485.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    124. Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients. Antimicrob Agents Chemother. 2011 Mar; 55(3):1082-7. Schweizer ML, Furuno JP, Sakoulas G, Johnson JK, Harris AD, Shardell MD, McGregor JC, Thom KA, Perencevich EN. PMID: 21173172; PMCID: PMC3067101.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCells
    125. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy. Ann Pharmacother. 2010 Dec; 44(12):2001-6. Le J, Bookstaver PB, Rudisill CN, Hashem MG, Iqbal R, James CL, Sakoulas G. PMID: 21119097.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    126. Combinatorial phenotypic signatures distinguish persistent from resolving methicillin-resistant Staphylococcus aureus bacteremia isolates. Antimicrob Agents Chemother. 2011 Feb; 55(2):575-82. Seidl K, Bayer AS, Fowler VG, McKinnell JA, Abdel Hady W, Sakoulas G, Yeaman MR, Xiong YQ. PMID: 21098242; PMCID: PMC3028773.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCellsCTClinical Trials
    127. Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study. PLoS One. 2010 Jul 02; 5(7):e11432. Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Sakoulas G, Perencevich EN. PMID: 20625395; PMCID: PMC2896397.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    128. Factors influencing time to vancomycin-induced clearance of nonendocarditis methicillin-resistant Staphylococcus aureus bacteremia: role of platelet microbicidal protein killing and agr genotypes. J Infect Dis. 2010 Jan 15; 201(2):233-40. Moise PA, Forrest A, Bayer AS, Xiong YQ, Yeaman MR, Sakoulas G. PMID: 20001853; PMCID: PMC2819315.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    129. Enhanced expression of dltABCD is associated with the development of daptomycin nonsusceptibility in a clinical endocarditis isolate of Staphylococcus aureus. J Infect Dis. 2009 Dec 15; 200(12):1916-20. Yang SJ, Kreiswirth BN, Sakoulas G, Yeaman MR, Xiong YQ, Sawa A, Bayer AS. PMID: 19919306; PMCID: PMC2779839.
      View in: PubMed   Mentions: 81     Fields:    Translation:HumansCells
    130. Clinical outcomes with daptomycin: a post-marketing, real-world evaluation. Clin Microbiol Infect. 2009 Dec; 15 Suppl 6:11-6. Sakoulas G. PMID: 19917022.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    131. Polyphyletic emergence of linezolid-resistant staphylococci in the United States. Antimicrob Agents Chemother. 2010 Feb; 54(2):742-8. Wong A, Reddy SP, Smyth DS, Aguero-Rosenfeld ME, Sakoulas G, Robinson DA. PMID: 19933808; PMCID: PMC2812165.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    132. Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions. Lancet Infect Dis. 2009 Oct; 9(10):617-24. Moise PA, North D, Steenbergen JN, Sakoulas G. PMID: 19778764.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    133. Reduced biofilm production associated with increasing linezolid MICs among linezolid-resistant staphylococci. J Antimicrob Chemother. 2009 Nov; 64(5):1114-5. Dandache P, Moise PA, Orsini J, Montecalvo M, Sakoulas G. PMID: 19734169.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    134. Relationship between population density of attorneys and prevalence of methicillin-resistant Staphylococcus aureus: is medical-legal pressure on physicians a driving force behind the development of antibiotic resistance? Am J Ther. 2009 Sep-Oct; 16(5):e1-6. Sakoulas G, Wormser GP, Visintainer P, Aronow WS, Nadelman RB. PMID: 19955854.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    135. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience. Clin Ther. 2009 Sep; 31(9):1936-45. Sakoulas G, Brown J, Lamp KC, Friedrich LV, Lindfield KC. PMID: 19843483.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    136. Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model. Antimicrob Agents Chemother. 2009 Oct; 53(10):4549-55. LaPlante KL, Sakoulas G. PMID: 19620335; PMCID: PMC2764192.
      View in: PubMed   Mentions: 13     Fields:    Translation:Cells
    137. Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia. Antimicrob Agents Chemother. 2009 Sep; 53(9):3894-901. Harigaya Y, Bulitta JB, Forrest A, Sakoulas G, Lesse AJ, Mylotte JM, Tsuji BT. PMID: 19596879; PMCID: PMC2737835.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    138. Accessory gene regulator dysfunction: an advantage for Staphylococcus aureus in health-care settings? J Infect Dis. 2009 May 15; 199(10):1558-9. Sakoulas G, Moise PA, Rybak MJ. PMID: 19392634.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    139. Loss of vancomycin bactericidal activity against accessory gene regulator (agr) dysfunctional Staphylococcus aureus under conditions of high bacterial density. Diagn Microbiol Infect Dis. 2009 Jun; 64(2):220-4. Tsuji BT, Harigaya Y, Lesse AJ, Sakoulas G, Mylotte JM. PMID: 19345040.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    140. Genotypic and phenotypic relationships among methicillin-resistant Staphylococcus aureus from three multicentre bacteraemia studies. J Antimicrob Chemother. 2009 May; 63(5):873-6. Moise PA, Smyth DS, Robinson DA, El-Fawal N, McCalla C, Sakoulas G. PMID: 19261624; PMCID: PMC2667134.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    141. Vancomycin ototoxicity: a reevaluation in an era of increasing doses. Antimicrob Agents Chemother. 2009 Feb; 53(2):483-6. Forouzesh A, Moise PA, Sakoulas G. PMID: 19001107; PMCID: PMC2630630.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    142. Daptomycin for soft tissue infection and neutropenia in a myelogenous leukemia patient who failed prior vancomycin therapy. Clin Adv Hematol Oncol. 2008 Nov; 6(11):813-5. Sakoulas G. PMID: 19194364.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    143. Cryptococcal infection presenting as cellulitis in a renal transplant recipient. Transpl Infect Dis. 2009 Feb; 11(1):68-71. Orsini J, Nowakowski J, Delaney V, Sakoulas G, Wormser GP. PMID: 19000155.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    144. Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2008 Sep; 52(9):3441-3. McCalla C, Smyth DS, Robinson DA, Steenbergen J, Luperchio SA, Moise PA, Fowler VG, Sakoulas G. PMID: 18606839; PMCID: PMC2533503.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    145. Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients. J Clin Microbiol. 2008 Sep; 46(9):2890-6. Lalani T, Federspiel JJ, Boucher HW, Rude TH, Bae IG, Rybak MJ, Tonthat GT, Corey GR, Stryjewski ME, Sakoulas G, Chu VH, Alder J, Steenbergen JN, Luperchio SA, Campion M, Woods CW, Fowler VG. PMID: 18596141; PMCID: PMC2546778.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCells
    146. Clinical rationale for treatment of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin. J Clin Microbiol. 2008 Jul; 46(7):2471; author reply 2471-2. Gqada Z, Marais B, Wasserman E, Bamford C, Orth H, Sakoulas G, Rose W, Rybak MJ, Pillai S, Alder J, Moellering RC, Eliopoulos GM. PMID: 18614667; PMCID: PMC2446886.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    147. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin Infect Dis. 2008 Jun 01; 46 Suppl 5:S360-7. Sakoulas G, Moellering RC. PMID: 18462091.
      View in: PubMed   Mentions: 97     Fields:    Translation:HumansCells
    148. Relationship of linezolid minimum inhibitory concentration and time to bacterial eradication in treatment for methicillin-resistant Staphylococcus aureus infection. Ann Pharmacother. 2008 Apr; 42(4):592-3. Moise PA, Castro RS, Sul C, Forrest A, Sakoulas G. PMID: 18349303.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    149. Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic model. J Antimicrob Chemother. 2008 May; 61(5):1099-102. Rose WE, Kaatz GW, Sakoulas G, Rybak MJ. PMID: 18263568.
      View in: PubMed   Mentions: 4     Fields:    Translation:Cells
    150. Microbiological effects of prior vancomycin use in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2008 Jan; 61(1):85-90. Moise PA, Smyth DS, El-Fawal N, Robinson DA, Holden PN, Forrest A, Sakoulas G. PMID: 18042628.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCellsCTClinical Trials
    151. Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin. J Clin Microbiol. 2008 Jan; 46(1):220-4. Sakoulas G, Rose W, Rybak MJ, Pillai S, Alder J, Moellering RC, Eliopoulos GM. PMID: 18003803; PMCID: PMC2224245.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    152. daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother. 2008 Mar; 52(3):831-6. Rose WE, Leonard SN, Sakoulas G, Kaatz GW, Zervos MJ, Sheth A, Carpenter CF, Rybak MJ. PMID: 17999971; PMCID: PMC2258488.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    153. Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob Agents Chemother. 2008 Jan; 52(1):269-78. Jones T, Yeaman MR, Sakoulas G, Yang SJ, Proctor RA, Sahl HG, Schrenzel J, Xiong YQ, Bayer AS. PMID: 17954690; PMCID: PMC2223911.
      View in: PubMed   Mentions: 161     Fields:    Translation:HumansCells
    154. Daptomycin in the treatment of bacteremia. Am J Med. 2007 Oct; 120(10 Suppl 1):S21-7. Sakoulas G, Golan Y, Lamp KC, Friedrich LV, Russo R. PMID: 17904947.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    155. Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus. Clin Infect Dis. 2007 Sep 01; 45(5):601-8. Boucher HW, Sakoulas G. PMID: 17682996.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    156. Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother. 2007 Jul; 51(7):2582-6. Moise PA, Sakoulas G, Forrest A, Schentag JJ. PMID: 17452488; PMCID: PMC1913284.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCells
    157. Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function. J Antimicrob Chemother. 2007 Jun; 59(6):1190-3. Rose WE, Rybak MJ, Tsuji BT, Kaatz GW, Sakoulas G. PMID: 17434881.
      View in: PubMed   Mentions: 15     Fields:    Translation:Cells
    158. Daptomycin nonsusceptibility in Staphylococcus aureus with reduced vancomycin susceptibility is independent of alterations in MprF. Antimicrob Agents Chemother. 2007 Jun; 51(6):2223-5. Pillai SK, Gold HS, Sakoulas G, Wennersten C, Moellering RC, Eliopoulos GM. PMID: 17404001; PMCID: PMC1891363.
      View in: PubMed   Mentions: 46     Fields:    Translation:HumansCells
    159. Clinical update on the diagnosis and treatment of bacterial endocarditis. Compr Ther. 2007; 33(4):192-207. Dandache P, Aronow WS, Sakoulas G. PMID: 18025611.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    160. Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2007 Mar; 51(3):1089-91. Tsuji BT, Rybak MJ, Lau KL, Sakoulas G. PMID: 17158941; PMCID: PMC1803123.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    161. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob Agents Chemother. 2006 Apr; 50(4):1581-5. Sakoulas G, Alder J, Thauvin-Eliopoulos C, Moellering RC, Eliopoulos GM. PMID: 16569891; PMCID: PMC1426932.
      View in: PubMed   Mentions: 87     Fields:    Translation:Cells
    162. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia. J Antimicrob Chemother. 2006 Apr; 57(4):699-704. Sakoulas G, Gold HS, Cohen RA, Venkataraman L, Moellering RC, Eliopoulos GM. PMID: 16464892.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    163. Adaptation of methicillin-resistant Staphylococcus aureus in the face of vancomycin therapy. Clin Infect Dis. 2006 Jan 01; 42 Suppl 1:S40-50. Sakoulas G, Moellering RC, Eliopoulos GM. PMID: 16323119.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCells
    164. Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob Agents Chemother. 2005 Jul; 49(7):2687-92. Sakoulas G, Eliopoulos GM, Fowler VG, Moellering RC, Novick RP, Lucindo N, Yeaman MR, Bayer AS. PMID: 15980337; PMCID: PMC1168700.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    165. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J Infect Dis. 2004 Sep 15; 190(6):1140-9. Fowler VG, Sakoulas G, McIntyre LM, Meka VG, Arbeit RD, Cabell CH, Stryjewski ME, Eliopoulos GM, Reller LB, Corey GR, Jones T, Lucindo N, Yeaman MR, Bayer AS. PMID: 15319865.
      View in: PubMed   Mentions: 173     Fields:    Translation:HumansCells
    166. Effects of glucose on fsr-mediated biofilm formation in Enterococcus faecalis. J Infect Dis. 2004 Sep 01; 190(5):967-70. Pillai SK, Sakoulas G, Eliopoulos GM, Moellering RC, Murray BE, Inouye RT. PMID: 15295702.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    167. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA. J Infect Dis. 2004 Jul 15; 190(2):311-7. Meka VG, Pillai SK, Sakoulas G, Wennersten C, Venkataraman L, DeGirolami PC, Eliopoulos GM, Moellering RC, Gold HS. PMID: 15216466.
      View in: PubMed   Mentions: 73     Fields:    Translation:HumansCells
    168. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol. 2004 Jun; 42(6):2398-402. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC, Eliopoulos GM. PMID: 15184410; PMCID: PMC427878.
      View in: PubMed   Mentions: 240     Fields:    Translation:HumansCellsCTClinical Trials
    169. Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy. Clin Infect Dis. 2004 Jun 15; 38(12):1700-5. Moise-Broder PA, Sakoulas G, Eliopoulos GM, Schentag JJ, Forrest A, Moellering RC. PMID: 15227615.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCells
    170. Hematogenous enterococcal vertebral osteomyelitis: report of 2 cases and review of the literature. J Infect. 2004 May; 48(4):354-62. Tarr PE, Sakoulas G, Ganesan A, Smith MA, Lucey DR. PMID: 15066338.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    171. Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin. Clin Infect Dis. 2004 Apr 15; 38(8):1188-91. Woods CW, Cheng AC, Fowler VG, Moorefield M, Frederick J, Sakoulas G, Meka VG, Tenover FC, Zwadyk P, Wilson KH. PMID: 15095227.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    172. Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia. Emerg Infect Dis. 2003 Jun; 9(6):657-64. Schwaber MJ, Wright SB, Carmeli Y, Venkataraman L, DeGirolami PC, Gramatikova A, Perl TM, Sakoulas G, Gold HS. PMID: 12781004; PMCID: PMC3000153.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    173. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2003 May; 47(5):1714-8. Sakoulas G, Eliopoulos GM, Alder J, Eliopoulos CT. PMID: 12709345; PMCID: PMC153308.
      View in: PubMed   Mentions: 53     Fields:    Translation:AnimalsCells
    174. Introduction of erm(C) into a linezolid- and methicillin-resistant Staphylococcus aureus does not restore linezolid susceptibility. J Antimicrob Chemother. 2003 Apr; 51(4):1039-41. Sakoulas G, Gold HS, Venkataraman L, Moellering RC, Ferraro MJ, Eliopoulos GM. PMID: 12728937.
      View in: PubMed   Mentions: 4     Fields:    Translation:Cells
    175. Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J Infect Dis. 2003 Mar 15; 187(6):929-38. Sakoulas G, Eliopoulos GM, Moellering RC, Novick RP, Venkataraman L, Wennersten C, DeGirolami PC, Schwaber MJ, Gold HS. PMID: 12660939.
      View in: PubMed   Mentions: 84     Fields:    Translation:HumansCells
    176. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003 Jan 01; 36(1):53-9. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. PMID: 12491202.
      View in: PubMed   Mentions: 528     Fields:    Translation:HumansCells
    177. Prevalence of the fsr locus in Enterococcus faecalis infections. J Clin Microbiol. 2002 Jul; 40(7):2651-2. Pillai SK, Sakoulas G, Gold HS, Wennersten C, Eliopoulos GM, Moellering RC, Inouye RT. PMID: 12089299; PMCID: PMC120556.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    178. Methicillin-susceptible Staphylococcus aureus: believe it, or not. Arch Intern Med. 2001 May 14; 161(9):1237-8. Sakoulas G, Degirolami PC, Gold HS. PMID: 11343454.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    179. Brainstem and striatal encephalitis complicating Mycoplasma pneumoniae pneumonia: possible benefit of intravenous immunoglobulin. Pediatr Infect Dis J. 2001 May; 20(5):543-5. Sakoulas G. PMID: 11368117.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    180. Corynebacterium jeikeium native valve endocarditis following femoral access for coronary angiography. Clin Infect Dis. 2001 Apr 01; 32(7):E120-1. Ross MJ, Sakoulas G, Manning WJ, Cohn WE, Lisbon A. PMID: 11264050.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    181. Successful use of cyclosporine in the treatment of glucocorticoid- resistant nongranulomatous chronic idiopathic enterocolitis. Gastroenterology. 1999 Nov; 117(5):1259-60. Sakoulas G, Anastopoulos H. PMID: 10610339.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    182. Hypercalcemia in an AIDS patient treated with growth hormone. AIDS. 1997 Sep; 11(11):1353-6. Sakoulas G, Tritos NA, Lally M, Wanke C, Hartzband P. PMID: 9302445.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    183. [Role of endogenous basic fibroblast growth factor in experimental duodenal ulcer]. Orv Hetil. 1995 Jul 09; 136(28):1501-3. Sándor Z, Kusstatscher S, Sakoulas G, Szabó S. PMID: 7637967.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    184. Molecular and cellular basis of ulcer healing. Scand J Gastroenterol Suppl. 1995; 208:3-8. Szabo S, Kusstatscher S, Sandor Z, Sakoulas G. PMID: 7777801.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    185. Growth factors: new 'endogenous drugs' for ulcer healing. Scand J Gastroenterol Suppl. 1995; 210:15-8. Szabo S, Kusstatscher S, Sakoulas G, Sandor Z, Vincze A, Jadus M. PMID: 8578198.
      View in: PubMed   Mentions: 13     Fields:    Translation:Animals
    186. Genomic sequences capable of committing mouse and rat fibroblasts to adipogenesis. Nucleic Acids Res. 1993 May 11; 21(9):2223-8. Colón-Teicher L, Wise LS, Martino JJ, Baskin L, Sakoulas G, Pollack RE, Chen S. PMID: 8502564; PMCID: PMC309488.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    187. Excess wild-type p53 blocks initiation and maintenance of simian virus 40 transformation. Mol Cell Biol. 1991 Jul; 11(7):3472-83. Fukasawa K, Sakoulas G, Pollack RE, Chen S. PMID: 1646391; PMCID: PMC361080.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    George's Networks
    Concepts (437)
    Derived automatically from this person's publications.
    Co-Authors (33)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department